Methylphenidate and Ciclopirox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylphenidate (methylphenidate) and Ciclopirox (ciclopirox). Common drug interactions include automatic bladder among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Methylphenidate and Ciclopirox. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,217 Methylphenidate users. Check the latest studies of Methylphenidate.

What is Ciclopirox?

Ciclopirox has active ingredients of ciclopirox. eHealthMe is studying from 2,646 Ciclopirox users. Check the latest studies of Ciclopirox.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

24 people who take Methylphenidate and Ciclopirox together, and have interactions are studied.

Methylphenidate and Ciclopirox drug interactions.

What are the common drug interactions of Methylphenidate and Ciclopirox, by gender? *:

female:

  1. Automatic bladder (nerve impulses between the bladder and the spinal cord remain intact and the bladder can be trained to empty by reflex (spastic) action)
  2. Back pain
  3. Cataract (clouding of the lens inside the eye)
  4. Dizziness
  5. Ear infection
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  7. Influenza
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  10. Face injury

male:

  1. Anxiety
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Calcinosis (calcium deposits in any soft tissue)
  4. Diarrhoea
  5. Foot fracture
  6. Fracture
  7. Hepatic enzyme increased
  8. Insomnia (sleeplessness)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Pruritus (severe itching of the skin)

What are the common drug interactions of Methylphenidate and Ciclopirox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Diarrhoea
  3. Drug ineffective
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Pruritus (severe itching of the skin)
  6. Skin exfoliation (removal of the oldest dead skin cells)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

n/a

50-59:

  1. Calcinosis (calcium deposits in any soft tissue)
  2. Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)
  3. Depression
  4. Eye discharge
  5. Eye infection
  6. Eye irritation
  7. Eye pain
  8. Eye pruritus (eye itching)
  9. Foreign body sensation in eyes (feeling of something in eye)
  10. Lacrimation increased

60+:

  1. Death
  2. Limb injury
  3. Lower limb fracture
  4. Muscular weakness (muscle weakness)
  5. Nausea (feeling of having an urge to vomit)
  6. Onychomycosis (fungal infection of the nail)
  7. Pain in extremity
  8. Renal impairment (severely reduced kidney function)
  9. Skin ulcer
  10. Weight decreased

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 62.50%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 45.83%
  3. Hypersensitivity: 2 people, 8.33%
  4. Hiv Infection: 2 people, 8.33%
  5. Drowsiness: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate and Ciclopirox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylphenidate and Ciclopirox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylphenidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ciclopirox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylphenidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ciclopirox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate and ciclopirox (the active ingredients of Methylphenidate and Ciclopirox, respectively), and Methylphenidate and Ciclopirox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: